NCT03973840View on ClinicalTrials.gov

Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 15, 2018

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Hypogonadism, Male
Interventions
DRUG

Testosterone Undecanoate

dose was given orally and allowed to reach steady state

Trial Locations (1)

60062

Clarus Therapeutics, Inc, Northbrook

Sponsors
All Listed Sponsors
collaborator

Celerion; Syneos Health; ARUP Laboratories

UNKNOWN

lead

Clarus Therapeutics, Inc.

INDUSTRY

NCT03973840 - Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes | Biotech Hunter | Biotech Hunter